These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4758387)

  • 21. Effect of inoculation with neuraminidase-treated tumor cells on macrophage cytotoxicity in vitro.
    Alley CD; Snodgrass MJ
    Cancer Res; 1978 Aug; 38(8):2332-8. PubMed ID: 667829
    [No Abstract]   [Full Text] [Related]  

  • 22. An electron-microscope study of the effects of lysolecithin on BP8 ascites-tumour cells and phagocytes of mice, compared with the effects of a specific anti-tumour serum plus complement.
    Wilkinson PJ; Cater DB
    J Pathol; 1969 Feb; 97(2):219-30. PubMed ID: 5352800
    [No Abstract]   [Full Text] [Related]  

  • 23. Protection by subcellular fractions prepared from lymph-nodes and spleens of specifically allergized C57 BL mice against fatal challenge with BP8 ascites tumour cells in C3H mice.
    Fraser LB; Cater DB
    Br J Exp Pathol; 1972 Apr; 53(2):98-110. PubMed ID: 4624270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of tumor-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumor-free syngeneic mice. IV. Search for this antigen on syngeneic embryonic tissues.
    Rejthar A
    Folia Biol (Praha); 1974; 20(4):252-7. PubMed ID: 4412745
    [No Abstract]   [Full Text] [Related]  

  • 25. [Growth control of experimental tumour. I. Host protection against tumour by previous inoculation of plasmatic membrane of tumour cell (author's transl)].
    Gomes RM; Preza PA; Bastos VC; Coelho MG; Kovary K; de Castro Faria H
    Rev Bras Pesqui Med Biol; 1978 Oct; 11(4-5):229-35. PubMed ID: 725135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of progressive neoplastic growth on the decarboxylation of DL-[1-14C]ornithine by lymphocytes from C3H/He tumor hosts.
    Vaage J; Agarwal S; Reinertsen JL
    Cancer Res; 1978 Aug; 38(8):2253-8. PubMed ID: 667820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ].
    Mazurek C; Stiffel C; Chalvet H; Biozzi G
    Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens.
    Treves AJ; Schechter B; Cohen IR; Feldman M
    J Immunol; 1976 Apr; 116(4):1059-64. PubMed ID: 1082902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular cyclic AMP content independent of ascites tumour growth rate in vivo.
    Jakobsen A
    Eur J Cancer (1965); 1975 Mar; 11(3):203-4. PubMed ID: 165941
    [No Abstract]   [Full Text] [Related]  

  • 32. Production of monoclonal antibodies against MM antigen: the serologic identification of MM antigen with Ly-6.2 alloantigen.
    Seto M; Takahashi T; Tanimoto M; Nishizuka Y
    J Immunol; 1982 Jan; 128(1):201-5. PubMed ID: 6976371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dependence on antigen dose and timing in the immune response of C3H mice to malignant ascites cells.
    Laursen ML; Laursen K
    Immunology; 1980 Jul; 40(3):403-10. PubMed ID: 7429535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on different stages in host-tumor relationship. 1. Differences in the behavior in vitro of ascites cells and lymphocytes derived from mice in early and later stages of tumor growth.
    Pikovski MA
    Isr J Med Sci; 1973 Feb; 9(2):136-44. PubMed ID: 4696151
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect on the growth of BP8 ascites tumour in C3H-C57 or C3H mice of "lymphocyte preparations" from C57 mice injected with BP8 cells and Freund's adjuvant.
    Cater DB; Waldmann H
    Br J Cancer; 1967 Mar; 21(1):124-36. PubMed ID: 6024503
    [No Abstract]   [Full Text] [Related]  

  • 36. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foreign H-2-like alloantigens of syngeneic tumor cells can act as new "restriction" molecules for the associative recognition of non-H-2 or tumor-associated antigens by lymphoid effectors in the cytostasis assay.
    Festenstein H; de Giorgi L; Matossian-Rogers A
    Transplant Proc; 1981 Dec; 13(4):1877-9. PubMed ID: 7330973
    [No Abstract]   [Full Text] [Related]  

  • 38. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
    Fujimoto S; Chen CH; Sabbadini E; Sehon AH
    J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor cell-specific transcription of a murine histocompatibility class Ib Q5 gene.
    Noguchi K; Kuwada E; Goto S; Egawa K
    Anticancer Res; 2004; 24(5C):3379-86. PubMed ID: 15515435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A method for producing anti-DNA antibodies in ascitic fluid of mice.
    Kitagawa Y; Okuhara E
    J Immunol Methods; 1976 Mar; 10(2-3):151-9. PubMed ID: 932438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.